PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets
Equine Pharmaceuticals
Product Description
PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets are indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona in horses. Safe, easy and effective, PROTAZIL starts working fast against disease where time matters.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| PROTAZIL® | 2.4lb Pail | No PK GTIN | 052850 |
Images
Important Safety Information
PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets: PROTAZIL® is contraindicated in horses with known hypersensitivity to diclazuril. Safe use in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. The safety of PROTAZIL® with concomitant therapies in horses has not been evaluated. For use in horses only. Do not use in horses intended for human consumption. For complete safety information please read label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global